Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, activators |
Mechanism KRAS inhibitors(GTPase KRas inhibitors), PINK1 activators(PTEN induced kinase 1 activators), PRKN activators(parkin RBR E3 ubiquitin protein ligase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Esophageal Squamous Cell Carcinoma | Preclinical | China | 17 Oct 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 01 Aug 2025 |





